Affiliations
AffiliationsItem in Clipboard
Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014Lia C Scott et al. Cancer. 2019.
. 2019 Oct 1;125(19):3412-3417. doi: 10.1002/cncr.32207. Epub 2019 Jul 8. AffiliationsItem in Clipboard
AbstractBackground: Triple-negative breast cancer (TNBC) has been associated with a more aggressive histology, poorer prognosis, and nonresponsiveness to hormone therapy. It is imperative that cancer research identify factors that drive disparities and focus on prevention.
Methods: Using the United States Cancer Statistics database, the authors examined differences between TNBCs compared with all other breast cancers with regard to age, race/ethnicity, and stage at diagnosis.
Results: A total of 1,151,724 cases of breast cancer were identified from 2010 through 2014, with the triple-negative phenotype accounting for approximately 8.4% of all cases. In unadjusted analyses, non-Hispanic black women (odds ratio [OR], 2.27; 95% CI, 2.23-2.31) and Hispanic women (OR, 1.22; 95% CI, 1.19-1.25) had higher odds of diagnosis when compared with non-Hispanic white women. Women aged <40 years had the highest odds of diagnosis compared with women aged 50 to 64 years (OR, 1.95; 95% CI, 1.90-2.01). Diagnosis at American Joint Committee on Cancer stage III and beyond conferred higher odds of the diagnosis of TNBC (OR for stage III, 1.69 [95% CI, 1.68-1.72]; and OR for stage IV, 1.47 [95% CI, 1.43-1.51]). Results varied slightly in adjusted analyses.
Conclusions: The results of the current study demonstrated that there is a significant burden of disease in TNBC diagnosed among women of color, specifically non-Hispanic black women, and younger women. Additional studies are needed to determine drivers of disparities between race, age, and stage of disease at diagnosis.
Keywords: continental population groups; epidemiology; ethnic groups; health status disparities; registries; triple-negative breast neoplasms.
© 2019 American Cancer Society.
Conflict of interest statementConflict of Interest: The authors made no disclosures.
Similar articlesIqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Iqbal J, et al. JAMA. 2015 Jan 13;313(2):165-73. doi: 10.1001/jama.2014.17322. JAMA. 2015. PMID: 25585328
Chen L, Li CI. Chen L, et al. Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1666-72. doi: 10.1158/1055-9965.EPI-15-0293. Epub 2015 Oct 13. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26464428 Free PMC article.
Sung H, DeSantis CE, Fedewa SA, Kantelhardt EJ, Jemal A. Sung H, et al. Cancer. 2019 Oct 1;125(19):3401-3411. doi: 10.1002/cncr.32293. Epub 2019 Jun 13. Cancer. 2019. PMID: 31190337
Vona-Davis L, Rose DP. Vona-Davis L, et al. J Womens Health (Larchmt). 2009 Jun;18(6):883-93. doi: 10.1089/jwh.2008.1127. J Womens Health (Larchmt). 2009. PMID: 19514831 Review.
Prakash O, Hossain F, Danos D, Lassak A, Scribner R, Miele L. Prakash O, et al. Front Public Health. 2020 Dec 22;8:576964. doi: 10.3389/fpubh.2020.576964. eCollection 2020. Front Public Health. 2020. PMID: 33415093 Free PMC article. Review.
Dang MN, Suri S, Li K, Casas CG, Stigliano G, Riley RS, Scully MA, Hoover EC, Aboeleneen SB, Kramarenko GC, Day ES. Dang MN, et al. Adv Ther (Weinh). 2024 Jun;7(6):2300426. doi: 10.1002/adtp.202300426. Epub 2024 Apr 26. Adv Ther (Weinh). 2024. PMID: 39006318
Zajac KK, Malla S, Babu RJ, Raman D, Tiwari AK. Zajac KK, et al. Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1779. doi: 10.1002/cnr2.1779. Epub 2023 Jan 12. Cancer Rep (Hoboken). 2023. PMID: 36632988 Free PMC article. Review.
Console L, Scalise M. Console L, et al. Life (Basel). 2022 Apr 21;12(5):618. doi: 10.3390/life12050618. Life (Basel). 2022. PMID: 35629286 Free PMC article. Review.
Makhani SS, Bouz A, Stavros S, Zucker I, Tercek A, Chung-Bridges K. Makhani SS, et al. Cureus. 2022 Jul 21;14(7):e27120. doi: 10.7759/cureus.27120. eCollection 2022 Jul. Cureus. 2022. PMID: 36000130 Free PMC article.
Pollock NC, Ramroop JR, Hampel H, Troester MA, Conway K, Hu JJ, Freudenheim JL, Olopade OI, Huo D, Ziv E, Neuhausen SL, Stevens P, McElroy JP, Toland AE. Pollock NC, et al. Breast Cancer Res Treat. 2022 Apr;192(3):639-648. doi: 10.1007/s10549-022-06509-3. Epub 2022 Mar 14. Breast Cancer Res Treat. 2022. PMID: 35286522 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3